| Company Name: |
Shanghai Hongye Biotechnology Co. Ltd
|
| Tel: |
400-9205774 |
| Email: |
sales@glpbio.cn |
| Products Intro: |
Product Name:Resolvin E1
CAS:552830-51-0
Purity:>98% Package:1mg;10mg;50mg;100mg;
|
| Company Name: |
ChemeGen(Shanghai) Biotechnology Co.,Ltd.
|
| Tel: |
18818260767 |
| Email: |
sales@chemegen.com |
| Products Intro: |
Product Name:Resolvin E1
CAS:552830-51-0
Purity:98% Package:10 mg;50 mg;100 mg;500 mg;1 g;5 g;10 g
|
| Company Name: |
Energy Chemical
|
| Tel: |
021-58432009 400-005-6266 |
| Email: |
marketing@energy-chemical.com |
| Products Intro: |
Product Name:ResolvinE1
CAS:552830-51-0
Purity:NULL Package:100g;10g;25g;50g Remarks:NULL
|
- Resolvin E1
-
- $1850.00
-
2026-04-22
- CAS:552830-51-0
- Purity:
- Supply Ability: 10g
|
| | Resolvin E1 Basic information |
| Product Name: | Resolvin E1 | | Synonyms: | Resolvin E1;6,8,10,14,16-Eicosapentaenoic acid, 5,12,18-trihydroxy-, (5S,6Z,8E,10E,12R,14Z,16E,18R)-;Eicosapentaenoic Acid Impurity 15;Resolvin E1
DISCONTINUED, offer R144690;Resolvin E1,Resolvin E-1;5S,12R,18R-Trihydroxy-6Z,8E,10E,14Z,16E-eicosapentaenoic acid;RvE1 | | CAS: | 552830-51-0 | | MF: | C20H30O5 | | MW: | 350.4492 | | EINECS: | | | Product Categories: | Aliphatics;Inhibitors;Intermediates & Fine Chemicals;Pharmaceuticals | | Mol File: | 552830-51-0.mol |  |
| | Resolvin E1 Chemical Properties |
| Boiling point | 591.3±50.0 °C(Predicted) | | density | 1.112±0.06 g/cm3(Predicted) | | storage temp. | Store at -80°C, protect from light | | solubility | DMF: 50 mg/ml; Ethanol: 50 mg/ml; PBS (pH 7.2): .05 mg/ml | | form | Liquid | | pka | 4.66±0.10(Predicted) | | color | Colorless to light yellow |
| | Resolvin E1 Usage And Synthesis |
| Uses | Resolvin E1 is an omega-3 polyunsaturated fatty acid derivative that exhibits potent anti-inflammatory, pro-resolution, and anti-nociceptive effects. Resolvin E1 has been shown to inhibit neuropathic pain and spinal cord microgial activation following peripheral nerve injury. | | Definition | ChEBI: Resolvin E1 is a resolvin that is (6Z,8E,10E,14Z,16E)-icosa-6,8,10,14,16-pentaenoic acid which is substituted at positions 5, 12 and 18 by hydroxy groups (the 5S,12R,18R stereoisomer). It has a role as an anti-inflammatory agent and a human xenobiotic metabolite. It is a nonclassic icosanoid, a long-chain fatty acid, a resolvin, a triol and a hydroxy polyunsaturated fatty acid. It is a conjugate acid of a resolvin E1(1-). | | in vivo | Resolvin E1 (1.0 μg per mouse; 50 μg/kg; i.p.; on days -8, -1, and 0) protects mice from TNBS (2,4,6-trinitrobenzene sulfonic acid) colitis[1]. | Animal Model: | 6- to 8-week-old female BALB/c mice (TNBS colitis model)[1] | | Dosage: | 1.0 μg per mouse; 50 μg/kg | | Administration: | i.p.; on days -8, -1, and 0 before the induction of colitis | | Result: | Reduced overall mortality, which was 25% and 62.5% at 1.0 μg per mouse and 50 μg/kg, respectively. |
| | IC 50 | Human Endogenous Metabolite |
| | Resolvin E1 Preparation Products And Raw materials |
|